ストックスクリーナーアプリを入手
14.56
1.82%
0.26
前日終値:
$14.30
開ける：
$14.31
24時間の取引高:
233.78K
Relative Volume:
1.35
時価総額：
$209.99M
収益：
$6.39M
当期純損益:
$-117.26M
株価収益率:
-1.1666
EPS:
-12.4807
ネットキャッシュフロー:
$-79.08M
1週間 パフォーマンス:
+4.00%
1か月 パフォーマンス:
+37.49%
6か月 パフォーマンス:
+53.26%
1年 パフォーマンス:
+7.14%
1日の値動き範囲:
$13.37
$14.67
1週間の範囲:
$13.37
$15.55
52週間の値動き範囲:
$5.2044
$55.89
Korro Bio Inc Stock (KRRO) Company Profile
Compare KRRO vs VRTX, REGN, ARGX, ALNY, RVMD
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
KRRO
Korro Bio Inc
|
14.56 | 209.99M | 6.39M | -117.26M | -79.08M | -12.48 |
VRTX
Vertex Pharmaceuticals Inc
|
485.39 | 123.19B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
664.52 | 69.67B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
877.62 | 54.58B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
298.76 | 39.89B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
186.88 | 39.73B | 742.00K | -1.37B | -1.07B | -7.0731 |
Korro Bio Inc Stock (KRRO) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-03-13 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2026-02-17 | アップグレード | William Blair | Mkt Perform → Outperform |
| 2026-01-29 | アップグレード | Chardan Capital Markets | Neutral → Buy |
| 2026-01-29 | アップグレード | H.C. Wainwright | Neutral → Buy |
| 2026-01-29 | アップグレード | Piper Sandler | Neutral → Overweight |
| 2026-01-28 | アップグレード | Cantor Fitzgerald | Neutral → Overweight |
| 2026-01-28 | アップグレード | Oppenheimer | Perform → Outperform |
| 2025-11-13 | ダウングレード | Cantor Fitzgerald | Overweight → Neutral |
| 2025-11-13 | ダウングレード | Chardan Capital Markets | Buy → Neutral |
| 2025-11-13 | ダウングレード | H.C. Wainwright | Buy → Neutral |
| 2025-11-13 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2025-11-13 | ダウングレード | RBC Capital Mkts | Outperform → Sector Perform |
| 2025-11-13 | ダウングレード | Raymond James | Strong Buy → Mkt Perform |
| 2025-11-13 | ダウングレード | William Blair | Outperform → Mkt Perform |
| 2025-04-29 | 開始されました | Cantor Fitzgerald | Overweight |
| 2025-04-16 | 開始されました | Chardan Capital Markets | Buy |
| 2025-01-10 | 開始されました | Oppenheimer | Outperform |
| 2024-10-21 | 開始されました | Raymond James | Strong Buy |
| 2024-08-14 | 開始されました | William Blair | Outperform |
| 2024-03-28 | 繰り返されました | H.C. Wainwright | Buy |
| 2024-02-27 | 開始されました | BMO Capital Markets | Outperform |
| 2023-12-04 | 開始されました | H.C. Wainwright | Buy |
| 2023-11-29 | 開始されました | RBC Capital Mkts | Outperform |
| 2023-11-10 | 開始されました | Piper Sandler | Overweight |
| 2023-02-15 | ダウングレード | Chardan Capital Markets | Buy → Neutral |
| 2023-02-13 | ダウングレード | Cowen | Outperform → Market Perform |
| 2021-09-22 | ダウングレード | Goldman | Buy → Neutral |
| 2021-01-27 | アップグレード | JP Morgan | Neutral → Overweight |
| 2020-12-22 | 開始されました | B. Riley Securities | Buy |
| 2020-07-14 | 開始されました | Oppenheimer | Outperform |
| 2020-05-18 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2019-10-28 | 開始されました | Cowen | Outperform |
| 2019-10-28 | 開始されました | Goldman | Buy |
| 2019-10-28 | 開始されました | JP Morgan | Overweight |
すべてを表示
Korro Bio Inc (KRRO) 最新ニュース
Korro Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Price to earnings forward of Korro Bio, Inc. – NASDAQ:KRRO - TradingView
Price to sales forward of Korro Bio, Inc. – NASDAQ:KRRO - TradingView
Korro Bio, Inc. (KRRO) upgraded to buy: What does it mean for the stock? - MSN
Korro Bio, Inc. (KRRO) Upgraded to Buy: What Does It Mean for the Stock? - Yahoo Finance
KRRO Q1 2026 Earnings: EPS Beat Driven by Cost Control and Clinical ProgressRevenue Report - dars.gov.et
Korro Bio: Why Director Sales Temper a 'Strong Buy' Consensus - Kavout | AI
Korro Bio director Formela sells $1.54m in shares - Investing.com
Korro Bio director Formela sells $1.54m in shares By Investing.com - Investing.com South Africa
Form 4 Korro Bio Inc For: 7 July By Investing.com - Investing.com Canada
Price to book forward of Korro Bio, Inc. – NASDAQ:KRRO - TradingView
Form 144 Korro Bio For: 6 July By Investing.com - Investing.com Canada
Korro Bio, Inc. (KRRO) soars 17.6%: Is further upside left in the stock? - MSN
KRROKorro Bio Inc Options - Finviz
Form 144 Korro Bio For: 2 July By Investing.com - Investing.com India
Korro Bio, Inc.(NasdaqCM: KRRO) added to Russell 2500 Growth Benchmark - marketscreener.com
Korro Bio, Inc.(NasdaqCM: KRRO) added to Russell Microcap Growth Benchmark Index - marketscreener.com
Korro Bio, Inc.(NasdaqCM: KRRO) added to Russell 2000 Growth Benchmark - marketscreener.com
Korro Bio, Inc.(NasdaqCM: KRRO) added to Russell 3000E Growth Benchmark - marketscreener.com
Korro Bio, Inc.(NasdaqCM: KRRO) added to Russell Small Cap Comp Growth Benchmark - marketscreener.com
Korro Bio, Inc. Actuals & Estimates (NASDAQ:KRRO) - TradingView
KRRO Forecast — Price Target — Prediction for 2027 - TradingView
Form 4 Korro Bio Inc For: 24 June By Investing.com - Investing.com Nigeria
Korro Bio Insider Sold Shares Worth $2,458,582, According to a Recent SEC Filing - marketscreener.com
Korro Bio director Jean Francois Formela sells $2.45m in shares - Investing.com UK
Korro Bio (KRRO) director-affiliated Atlas funds sell 171K shares under 10b5-1 plan - Stock Titan
Form 144 Korro Bio For: 24 June By Investing.com - Investing.com India
Atlas Venture (KRRO) sells 101,579 shares on 06/23/2026, multiple Form 144 entries - Stock Titan
Atlas Venture sells KRRO common stock in late May–June 2026 (KRRO) - Stock Titan
Korro Bio (KRRO) Notches Modest Gain as Shares Consolidate Near Key ResistanceGap Down Bounce Plays - dars.gov.et
Form 144 Korro Bio For: 23 June By Investing.com - Investing.com South Africa
KRRO (NASDAQ: KRRO) selling holders report recent share sales - Stock Titan
Korro Bio Inc. (KRRO) Edges Lower Amid Consolidation PhaseUnusual Call Volume - dars.gov.et
Form 144 Korro Bio For: 22 June By Investing.com - Investing.com Australia
Atlas Venture sells KRRO (KRRO) stock — 2,441 and 419 shares reported - Stock Titan
KRRO proposes sale of 3,661 shares on Nasdaq (NASDAQ: KRRO); Atlas Venture recent disposals - Stock Titan
Korro Bio, Inc. (KRRO) Soars 17.6%: Is Further Upside Left in the Stock? - Yahoo Finance
Korro Bio (KRRO) Surges 17.6%: Volume Spike and Key Levels in FocusNarrow Range Breakout - dars.gov.et
Korro Bio COO Chappell sells $34,309 in company stock By Investing.com - Investing.com India
Korro Bio COO Chappell sells $34,309 in company stock - Investing.com UK
Korro Bio Inc (KRRO) Valuation: PE, PB & Fair Value Analysis - TradingKey
Korro Bio Inc (KRRO) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Korro Bio Inc (KRRO) Institutional Confidence - TradingKey
Korro Bio Inc (KRRO) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Korro Bio Inc (KRRO) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Korro Bio Inc (KRRO) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Korro Bio Inc (KRRO) 財務データ
収益
当期純利益
現金流量
EPS
Korro Bio Inc (KRRO) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| FORMELA JEAN FRANCOIS | Director |
Jul 06 '26 |
Sale |
13.96 |
9,323 |
130,149 |
146,305 |
2.64%
大文字化:
|
ボリューム (24 時間):